UNSPSC 51442213: Gadoterate meglumine

A gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.

UNSPSC 51442213 Gadoterate meglumine is a Commodity code representing a paramagnetic contrast agent used in magnetic resonance imaging procedures. State and local procurement activity under this code shows minimal alignment with the nominal pharmaceutical scope — recent opportunities posted under the code cover maintenance services for X-ray inspection equipment and bulk chemical supplies, neither of which constitute gadoterate meglumine or related medical imaging contrast agents. The mismatch between code and opportunity suggests either miscategorization in the source data or sporadic tagging practices by issuing bodies, limiting the utility of this code as a targeting vehicle for vendors supplying the stated product.

The two recent opportunities on record — Broward County Aviation Department's June 2026 RFI for Rapiscan X-ray system maintenance services and Pasco County's June 2026 RFQ for copper sulfate crystals and liquid — originate from county-level operations departments and reflect general facilities and equipment maintenance procurement rather than medical imaging supplies. No pattern of repeat buyers, geographic concentration, or sustained solicitation activity emerges from the source. If your firm supplies gadoterate meglumine or related MRI contrast media to state and local health systems or imaging centers, this UNSPSC code does not currently reflect meaningful procurement demand and should be deprioritized in favor of direct outreach to hospital purchasing departments and health department contracts units.